Tidings, Mostly Glad[ed note: We feature the musings of our favorite health and medicine writer, Michael Jorrin, a couple times a month, and we’ve taken the liberty of calling him “Doc Gumshoe” (he’s not a doctor). You’ll find no stock picks in his pieces, but hopefully will get plenty of insight into the medical matters he explains […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
A stock that this "resident doctor" you mentioned recommended in the past in this space was Antibe Therapeutics. I have...
$EYEG no position $IMMY long I will let Doc speak for himself. You need 3 different medications post op for cataract s...
$CATB is junk science. Shares will cool when people realize how flimsy the premise is. The lead drug is simply a conjug...
Will look into this again, Doc. I can tell you without further study that I would use a preparation of hyaluronic acid i...
athi $ PSDV – they made a bad deal with existing partner ALIM causing the shares to tank. I’m underwater on this an...
$PSDV NP $OCUL NP Sorry to hear the sad tale, athi. I've replaced my melted wings from ophtho investments gone bad way t...
Three interesting new technologies from SERAPH | The Angel's Advocate 1,First light-activated drug to treat pain A t...
Questioning the prognosis of @Fezziwig2008 (twitter handle) Long thesis? $CRBP Bear Thesis: The study itself seems ligh...
Meloxicam is an iv NSAID being developed by Recro Pharma ($REPH). Trevena is developing oliceridine, a mu opioid "b...
If using Voltaren or some other topical analgesic means you can reduce or omit the oral NSAID, that would "mitigate" the...
NSAID side effect study results are in! A ten year, 24,000 patient study at the Cleveland Clinic has addressed safety c...
REPH np. I'm interested in it as well. Meloxicam is of course an NSAID (Non-Steroidal Anti-Inflammatory) just like Ibupr...
HN: Essentially, a war will soon be on between iv meloxicam (REPH) and iv ketorolac (Toradol). What investors need to kn...
I've not provided an update on Recro for some time. I remain long in this undervalued microcap, and applaud it finally h...
Hi danmcco. Although the idea of using punctal plugs to provide dropless and injectionless medication to the eye and sur...
$IMMY. Imprimis The volume of complaints from patients in my practice that involve money paid to obtain care has be...
Dr. KSS article on Recro (Reph) and it's IV meloxicam was very interesting and as always, a great read. Like the doc, I...
Kenny: I am no expert on these, and Dr. Bonz knows far more about it than I do, but when I have patients with these, I t...
REPH- Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP Manufacturing Facility and Business Unit From Alker...
If anyone wants to see a totally cool 40-sec medical video, here is one. I love doing emergency endoscopy cases to stop ...
I'm not buying it no matter what. As a med student to staff physician I've been told how this new NSAID is better becaus...
Thanks oleg. That's quite sad what your son and you are going through. Aplastic anemia usually strikes somewhat younger ...
Not sure about that Doc.... NIH Research: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094288/ Wiki Report: Analges...
To Tim Putnam: Thank you for reading and commenting. The maximum dose of tolerable safe ibuprofen varies quite a lot ...
In addition to the closely-watched train of CHTP, the FDA is having another big meeting this week that has not been anno...
Dr. K I think synergy is valid expectation & then wonder about cocktail with Nsaid member. Small cost for "taste" of...
I have psioriatic arthritis, an autoimmune disease similar to RA. I have been through all the treatments in the article,...
Javelin is indeed an interesting company. Their flagship products is an injectable form of Dyclofenac--an NSAID called ...
The Therapeutic Goods Administration (TGA) cancelled the registration of lumiracoxib on Saturday due to reports of serio...